The High Dose Aflibercept DME Trial
Retina Synthesis - Un pódcast de Retina Synthesis
Categorías:
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
